SearchDictionaryMobileLogin

methyl 4-mercaptobutyrimidate

Subscribe to Selected New Research on methyl 4-mercaptobutyrimidate
12  relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: used as a cross-linking agent to study ribosomal proteins, by making disulfide linkages; RN given refers to parent cpd; structure

Also Known As:
2-iminothiolane; methyl 4-mercaptobutyrimidate hydrochloride

Bio-Agent Context: Research Results

-
Organic Chemicals: 42
-
Imides: 16
-
Imidoesters: 2
*
methyl 4-mercaptobutyrimidate: 12

Experts

1. Knapp, F F: 1 article (06/2000)
2. Hosono, M N: 1 article (06/2000)
3. Gautherot, E: 1 article (06/2000)
4. Chatal, J F: 1 article (06/2000)
5. Barbet, J: 1 article (06/2000)
6. Hosono, M: 1 article (06/2000)
7. Faivre-Chauvet, A: 1 article (06/2000)
8. Mishra, A K: 1 article (06/2000)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
11/15/2006 - "METHODS AND MATERIALS: 111In-DOTA-glycylglycylglycyl-l-p-isothiocyanatophenylalanine amide (GGGF)-m170 and 111In-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA) 2-iminothiolane (2IT)-m170, representing the same MAb and chelate with and without a cleavable linkage, were studied in 13 breast cancer and 26 prostate cancer patients. "
08/01/1985 - "When MCF-7 human breast cancer cells are incubated with [3H]estradiol or [3H]antiestrogen [alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbe ne (CI628M) or (Z)-1-[4-(2-[N-aziridinyl]ethoxy)phenyl] 1,2-diphenyl-1-butene (tamoxifen aziridine)] and nuclear estrogen-receptor complexes are extracted with 0.6 M KCl and then chemically cross-linked with the cross-linker 2-iminothiolane, the cross-linked receptor complexes sediment as a 5.4S species on 3 M urea-containing sucrose gradients, while the noncross-linked species are 4S. "
12/01/2002 - "The following studies are described in this article: the 99mTc-randiolabeling of 2-iminothiolane (2-IT) modified antibodies and 6-p-isothiocyanatobenzyl- diethylene-triamine penta-acetic acid (CITC-DTPA) immunoconjugates of anti-EGF-receptor antibodies murine ior egf/r3 and humanized h-R3; the analytical methods for quality control of the radiopharmaceutical such as instant thin layer chromatography-silica gel (ITLC-SG); the biological assessment of the radiolabeled molecule using flow cytometry analysis; in vitro stability studies with cysteine and DTPA challenge and the biodistribution studies in 4NMRI xenografted nude mice with U-87 human glioblastoma multiforme and MDA-MB-468 breast cancer cell lines. "
Order ALL the reference details at left...
2. Glioblastoma (Glioblastoma Multiforme)
3. Adenocarcinoma
4. Small Cell Lung Carcinoma (Small Cell Lung Cancer)
5. Osteosarcoma (Osteogenic Sarcoma)

Related Drugs and Biologics

1. Immunoconjugates (Immunoconjugate)
2. Antibodies
3. Acetic Acid (Vinegar)
4. Epidermal Growth Factor Receptor (EGF Receptor)
5. Epidermal Growth Factor (EGF)
6. Pentetic Acid (DTPA)
7. Cysteine (L-Cysteine)
8. 6- (4- isothiocyanatobenzyl)- diethylenetriamine pentaacetic acid
9. Org 31540 (PENTA)
10. silochrome

Best Treatments:
Research Summary Report
on Breast Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 3868 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>